3.58
-0.0913(-2.49%)
Currency In USD
| Previous Close | 3.67 |
| Open | 3.65 |
| Day High | 3.65 |
| Day Low | 3.58 |
| 52-Week High | 10.16 |
| 52-Week Low | 1.92 |
| Volume | 319 |
| Average Volume | 55,918 |
| Market Cap | 9.11M |
| PE | -1.66 |
| EPS | -2.16 |
| Moving Average 50 Days | 4.33 |
| Moving Average 200 Days | 3.55 |
| Change | -0.09 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $508.52 as of May 16, 2025 at a share price of $3.58. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $60.72 as of May 16, 2025 at a share price of $3.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
GlobeNewswire Inc.
May 07, 2025 12:19 PM GMT
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , May 07, 2025
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
GlobeNewswire Inc.
Apr 23, 2025 12:19 PM GMT
10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carcinogenThis
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
GlobeNewswire Inc.
Apr 17, 2025 12:19 PM GMT
Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), with high rele